Terms: = Endocrine gland cancer AND FANCF, FAF, 2188, ENSG00000183161, Q9NPI8, MGC126856 AND Treatment
11 results:
1. Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and fancf expression in ovarian carcinomas.
Moes-Sosnowska J; Rzepecka IK; Chodzynska J; Dansonka-Mieszkowska A; Szafron LM; Balabas A; Lotocka R; Sobiczewski P; Kupryjanczyk J
Cancer Biol Ther; 2019; 20(6):843-854. PubMed ID: 30822218
[TBL] [Abstract] [Full Text] [Related]
2. Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer.
Kessous R; Octeau D; Klein K; Tonin PN; Greenwood CMT; Pelmus M; Laskov I; Kogan L; Salvador S; Lau S; Yasmeen A; Gotlieb WH
Gynecol Oncol; 2018 Mar; 148(3):553-558. PubMed ID: 29395310
[TBL] [Abstract] [Full Text] [Related]
3. Promoter Hypermethylation of fancf and Susceptibility and Prognosis of Epithelial Ovarian cancer.
Ding JJ; Wang G; Shi WX; Zhou HH; Zhao EF
Reprod Sci; 2016 Jan; 23(1):24-30. PubMed ID: 26507869
[TBL] [Abstract] [Full Text] [Related]
4. RNA interference-mediated fancf silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation.
He M; Sun HG; Hao JY; Li YL; Yu JK; Yan YY; Zhao L; Li N; Wang Y; Bai XF; Yu ZJ; Zheng ZH; Mi XY; Wang EH; Wei MJ
Oncol Rep; 2013 May; 29(5):1721-9. PubMed ID: 23440494
[TBL] [Abstract] [Full Text] [Related]
5. Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin.
Jacquemont C; Simon JA; D'Andrea AD; Taniguchi T
Mol Cancer; 2012 Apr; 11():26. PubMed ID: 22537224
[TBL] [Abstract] [Full Text] [Related]
6. Promoter hypermethylation of fancf plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
Wang Z; Li M; Lu S; Zhang Y; Wang H
Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
[TBL] [Abstract] [Full Text] [Related]
7. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
[TBL] [Abstract] [Full Text] [Related]
8. CpG methylation of the FHIT, fancf, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.
Dhillon VS; Shahid M; Husain SA
Mol Cancer; 2004 Dec; 3():33. PubMed ID: 15574200
[TBL] [Abstract] [Full Text] [Related]
9. The Fanconi Anemia/BRCA signaling pathway: disruption in cisplatin-sensitive ovarian cancers.
D'Andrea AD
Cell Cycle; 2003; 2(4):290-2. PubMed ID: 12851475
[TBL] [Abstract] [Full Text] [Related]
10. High-dose chemotherapy in germ cell tumours: a large single centre experience.
Rick O; Beyer J; Kingreen D; Schwella N; Krusch A; Schleicher J; Kirsch A; Huhn D; Siegert W
Eur J Cancer; 1998 Nov; 34(12):1883-8. PubMed ID: 10023310
[TBL] [Abstract] [Full Text] [Related]
11. Oncocytomas of the submandibular gland. A series of 22 cases and a review of the literature.
Thompson LD; Wenig BM; Ellis GL
Cancer; 1996 Dec; 78(11):2281-7. PubMed ID: 8940996
[TBL] [Abstract] [Full Text] [Related]